Volgen
R.C.Kruizinga
R.C.Kruizinga
Onbekend partnerschap
Geverifieerd e-mailadres voor vumc.nl
Titel
Geciteerd door
Geciteerd door
Jaar
A review on CXCR4/CXCL12 axis in oncology: no place to hide
UM Domanska, RC Kruizinga, WB Nagengast, H Timmer-Bosscha, ...
European journal of cancer 49 (1), 219-230, 2013
7022013
CXCR4 inhibition with AMD3100 sensitizes prostate cancer to docetaxel chemotherapy
UM Domanska, H Timmer-Bosscha, WB Nagengast, THO Munnink, ...
Neoplasia 14 (8), 709-718, 2012
2202012
Role of chemokines and their receptors in cancer
RC Kruizinga, J Bestebroer, P Berghuis, CJC de Haas, TP Links, ...
Current pharmaceutical design 15 (29), 3396-3416, 2009
882009
Pregnancy-related hemangioblastoma progression and complications in von Hippel-Lindau disease
C Frantzen, RC Kruizinga, SJ Van Asselt, BA Zonnenberg, JWM Lenders, ...
Neurology 79 (8), 793-796, 2012
642012
Calculating optimal surveillance for detection of von Hippel–Lindau-related manifestations
RC Kruizinga, WJ Sluiter, EGE de Vries, BA Zonnenberg, CJ Lips, ...
Endocrine-Related Cancer 21 (1), 63-71, 2014
492014
The chemokine network, a newly discovered target in high grade gliomas
UM Domanska, RC Kruizinga, WFA den Dunnen, H Timmer-Bosscha, ...
Critical reviews in oncology/hematology 79 (2), 154-163, 2011
462011
Staphylococcal SSL5 binding to human leukemia cells inhibits cell adhesion to endothelial cells and platelets.
HCJ Walenkamp AM, Bestebroer J, Boer IG, Kruizinga R, Verheul HM, van Strijp JA
Cell Oncol, 1-10, 2010
36*2010
The incidence of consecutive manifestations in Von Hippel-Lindau disease
ANA van der Horst-Schrivers, WJ Sluiter, RC Kruizinga, ...
Familial Cancer 18, 369-376, 2019
182019
Vascular Endothelial Growth Factor A isoform mRNA expression in pediatric acute myeloid leukemia
RC Kruizinga, HJM de Jonge, KR Kampen, AME Walenkamp, E de Bont
Pediatric blood & cancer 56 (2), 294-297, 2011
142011
Difference in CXCR4 expression between sporadic and VHL-related hemangioblastoma
RC Kruizinga, DMS van Marion, WFA den Dunnen, JC de Groot, ...
Familial cancer 15, 607-616, 2016
132016
Pregnancy and von Hippel-Lindau disease
C Frantzen, SJ van Asselt, RC Kruizinga, C Abadie, I Coupier, S Richard, ...
Journal of Neurosurgery 118 (6), 1380-1382, 2013
42013
The incidence of consecutive manifestations of VHL disease
C Frantzen, RC Kruizinga, WJ Sluiter, BA Zonnenberg, CJ Lips, ...
Endocrine Abstracts 37, 2015
2015
CXCR4 expression in VHL-related and sporadic hemangioblastomas.
RC Kruizinga, WFA den Dunnen, EGE de Vries, TP Links, ...
Cancer Research 73 (8_Supplement), 93-93, 2013
2013
Role of VEGFA, CXCR4 and VHL mutation in tumour behaviour
RC Kruizinga
2013
Mitochondrial and bacterial peptides act on the formyl peptide receptor (FPR) to promote migration and proliferation in high grade glioblastoma cells
JC Boer, UM Domanska, RC Kruizinga, I Boer, CJC de Haas, EG de Vries, ...
Cancer Research 71 (8_Supplement), 1672-1672, 2011
2011
CXCR4 inhibition sensitizes prostate cancer cells to conventional chemotherapy in an in vitro co-culture model
UM Domanska, RC Kruizinga, WB Nagengast, HT Bosscha, EGE de Vries, ...
Cancer Research 71 (8_Supplement), 522-522, 2011
2011
P51. Pregnancy stimulates cerebellar hemangioblastoma growth in von Hippel-Lindau disease
C Frantzen, RC Kruizinga, SJ van Asselt, BA Zonnenberg, JWM Lenders, ...
2011
Sunitinib treatment induces up-regulation of CXCR4
U Kubacka, WB Nagengast, RC Kruizinga, MN Lub-deHooge, JA Gietema, ...
Cancer Research 70 (8_Supplement), 380-380, 2010
2010
Pregnancy-related hemangioblastoma progression and
C Frantzen, RC Kruizinga, SJ van Asselt
Het systeem kan de bewerking nu niet uitvoeren. Probeer het later opnieuw.
Artikelen 1–19